SCHEMBL7002332

SCHEMBL7002332

CN1C(=O)C(Br)=C(c2c(CCCCCCCCCCc3[nH]c4ccccc4c3C3=C(Br)C(=O)N(C)C3=O)[nH]c3ccccc23)C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38
ADORA1 P30542 1/20 0.38
CTSV O60911 2/20 0.38
CTSL P07711 2/20 0.38
MPO P05164 3/20 0.38
OXER1 Q8TDS5 1/20 0.37
ALDH1A1 P00352 5/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 3/20 0.36
CYP1A2 P05177 1/20 0.36
CDK4 P11802 1/20 0.35
PRKACA P17612 1/20 0.35
PRKACG P22612 1/20 0.35
PRKACB P22694 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6864924 1.00 GSK3B (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6860151 1.00 GSK3B (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6865292 1.00 GSK3B (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6867603 0.99 GSK3B (0.44) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6991740 0.96 GSK3B (0.44) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6867285 0.94 GSK3B (0.46) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6865687 0.89 CTSV (0.43) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6867178 0.88 CTSV (0.41) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6867979 0.83 HRH3 (0.39) GSK3BSIRT2SIRT1ADORA3ADORA2A
SCHEMBL6871063 0.82 PARP1 (0.36) GSK3BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109785-B1 INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF MALIGNANT AND OTHER DISEASES CAUSED BY PATHOLOGICAL CELL PROLIFERATION ZENTARIS AG (DE) 2003-01-02 EP disclosed